Skip to main content
. Author manuscript; available in PMC: 2009 Apr 17.
Published in final edited form as: Dev Psychopathol. 2008;20(2):529–546. doi: 10.1017/S0954579408000266

Table 1. Demographic data.

NP-BD SMD Control p Value
N 39 31 36
Age (years) 13.99 ± 2.63 12.29 ± 2.12 14.34 ± 2.28 .001
Gender (male), % (N) 53.80 (21) 61.30 (19) 55.60 (20) .81
IQ 110.08 ± 14.15 102.74 ± 14.36 115.61 ± 14.21 .002
CGAS 48.95 ± 12.41 47.50 ± 7.76 .60
No. of diagnoses 2.33 ± 1.30 2.55 ± 1.23 .49
Diagnoses, % (N)
 BP I 92.30 (36)
 BP II 7.70 (3)
 ADHD 46.20 (18) 77.40 (24) .02
 ODD 23.10 (9) 74.20 (23) .001
 Any anxiety 35.90 (14) 45.20 (14) .59
 GAD 15.40 (6) 29.00 (9) .28
 Separation anxiety 15.40 (6) 25.80 (8) .43
 Social phobia 20.50 (8) 9.70 (3) .37
 MDD 9.70 (3)
No. of medications when medicated 2.88 ± 1.16 2.29 ± 1.14 .12
Medications 82.10 (32) 45.20 (14) .003
 Antiepileptics 64.10 (25) 19.40 (6) .001
 Atypical antipsychotics 51.30 (20) 16.10 (5) .005
 Lithium 35.90 (14) 22.60 (7) .35
 Stimulants 35.90 (14) 29.00 (9) .73
 Antidepressants 23.10 (9) 12.90 (4) .44
Mood rating scores
 CDRS 30.05 ± 9.09 26.45 ± 5.24 .06
 YMRS 10.84 ± 6.73 9.83 ± 7.25 .56
 MASC t score 43.63 ± 11.35 44.75 ± 10.41 .77
Social function scores
 SRS 80.39 ± 17.30 83.27 ± 25.32 .94
 LIFE: family 2.70 ± 0.77 2.71 ± 0.87 .96
 LIFE: friends 3.03 ± 1.12 2.72 ± 1.02 .35

Note: NP-BD, narrow phenotype bipolar disorder; SMD, severe mood dysregulation; CGAS, Children’s Global Assessment Scale; BP, bipolar disorder; ADHD, attention-deficit/hyperactivity disorder; GAD, generalized anxiety disorder; MDD, major depressive disorder; ODD, oppositional defiant disorder; CDRS, Children’s Depression Rating Scale; YMRS, Young Mania Rating Scale; MASC, Manifest Anxiety Scale for Children; SRS, Social Reciprocity Scale; LIFE, Longitudinal Interval Follow-up Evaluation. All diagnoses are current.